TL;DRTelepatia raised $33M from a16z to reach half of Latin America’s 1.9M doctors by 2027. It already serves 14M patients across five countries.
Telepatia, an AI clinical assistant built for Latin American healthcare, has raised $33 million in a Series A led by Andreessen Horowitz. The company wants to reach half of the region’s 1.9 million doctors by the end of 2027. Total funding is now $42 million, with early backers including Palantir CTO Shyam Sankar, Rappi founder Simon Borrero, and Nubank founder David Velez.
The product transcribes consultations in real time, reviews medical records, flags potential errors, and makes live suggestions based on medical literature and clinical guidelines. CEO Nicolas Abad calls it “a second brain for the doctor.” At Hospital Mater Dei in Brazil, physicians use the tool an average of eight hours a day and recover 1.7 hours daily, according to company data.
The origin story is personal. Abad’s father, a physician, died in late 2022 at age 58 after a preventable drug interaction. He had spent years reading medical papers about his own illness, but an interaction between a hiccup treatment and a sleep medication proved fatal. “This is the product that would have saved my father as a patient, and that he would have loved as a doctor,” Abad said.
